Company Overview

TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio’s OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.

NASDAQ: TELA

$8.28

-0.41 (-4.72%)

Data Provided by Refinitiv.
Minimum 15 minutes delayed.

 

Latest Company Presentation

Stock Performance

Corporate Governance

Corporate Governance Documents

h

Code of Business Conduct & Ethics

h

Corporate Governance Guidelines

Governance Charters

h

Compensation Committee Charter

h

Nominating and Corporate Governance Committee Charter

h

Audit Committee Charter

FAQs

Where is TELA Bio’s corporate headquarters?

The Company’s corporate headquarters are located at 1 Great Valley Parkway, Suite 24, Malvern, PA 19355 and our telephone number is (484) 320-2930.

Where and when was TELA Bio incorporated?

TELA Bio, Inc. was incorporated in 2012 as a Delaware corporation.

On what stock exchange are TELA Bio shares traded, and what is the ticker symbol?

TELA Bio is listed on the NASDAQ Global Market under the symbol “TELA”.